Evidence map›Paper›PMID 29876667›Full record

ReviewCurrent allergy and asthma reports2018

Sulfonamide Drug Allergy.

Joshua M Dorn, Mollie Alpern, Caitlin McNulty, Gerald W Volcheck

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Sulfonamide Hypersensitivity.Clinical reviews in allergy & immunology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Outcome of trimethoprim-sulfamethoxazole challenge in previously reported patients with sulfa antibiotic allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  13. A Case Report of Antibiotic-Induced Aseptic Meningitis in Psoriasis.Hawai'i journal of health & social welfare · 2021
    Article
  14. Article
  15. Review
  16. Oral challenge with trimethoprim-sulfamethoxazole in patients with "sulfa" antibiotic allergy.The journal of allergy and clinical immunology. In practice · 2020
    Article
  17. Article
  18. Sulfonamide Allergies.Pharmacy (Basel, Switzerland) · 2019
    Review
  19. Drug hypersensitivity in HIV infection.Current opinion in allergy and clinical immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joshua M DornMayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA.
Mollie AlpernMayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA.
Caitlin McNultyMayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA.
Gerald W VolcheckMayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA. Volcheck.gerald@mayo.edu.
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewWe sought to review past and current literature on sulfonamide drug allergy and distill it in a practical manner to assist the clinician, specifically focusing on cross-reactivity and desensitization. RECENT

findingsThere do not appear to be consistent genetic markers to reliably predict features of or the presence hypersensitivity reactions. Recent evidence continues to alleviate early concerns cross-reactivity between sulfonamide antibiotics and non-antibiotics. Sulfonamide drug allergy is frequently encountered by the practicing clinician. For sulfonamide antibiotics, delayed rash is the most common clinical manifestation. There is no current evidence to support avoidance of all non-antibiotic sulfonamides in those with a reported allergy to sulfonamide antibiotics, although certain scenarios require caution. Available evidence supports the cautious reintroduction of sulfonamide antibiotics via desensitization, which is usually well tolerated and should be considered in those with strong indications for trimethoprim-sulfamethoxazole and a reported sulfonamide allergy.

Indexed as

Anti-Bacterial AgentsCross ReactionsDesensitization, ImmunologicDrug HypersensitivityHumansRisk FactorsSulfonamidesAnti-Bacterial AgentsSulfonamidesCross-reactivityCross-sensitivityDrug allergyHypersensitivitySulfonamide

Identifiers

PMID29876667
OpenAlexW2738526370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.